WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW), a diversified holding company, announced this week that its molecular hydrogen supplement subsidiary, Vital Reaction, has successfully launched an innovative new pocket inhaler called “Kencos” in late October.
The Kencos inhaler is seen as a healthier alternative to vaping or smoking, specially designed for individuals aiming to quit these habits. This launch signifies a vital step forward in the growth strategy of Vital Reaction, as it continues to innovate and expand its product range in the eCommerce domain.
Onfolio’s CEO, Dom Wells, expressed his optimism about the launch, stating, “One of the keys for growth of Vital Reaction is to launch new products, as you would expect with any eCommerce brand. Kencos has a mass appeal. It was great to see the team at Vital Reaction, led by Shaun Thresher, bring the product to market and have a successful launch.”
Shaun Thresher, the driving force behind the Kencos launch, shared his enthusiasm about the product’s potential impact. “We’ve been looking for ways to bring the benefits of Molecular Hydrogen to a wider audience, and this healthy alternative to vaping is an exciting way of doing so. The launch went as well as expected, and we’re looking forward to seeing Kencos become a core part of the Vital Reaction brand moving forwards,” said Thresher.
The initial sales figures of Kencos are promising. In October, Vital Reaction recorded product sales worth around $85,000, of which $14,500 were from sales of Kencos in just the final week of the month. This suggests that the new product accounted for 17% of revenue in merely ¼ of the time.
The successful launch of the Kencos inhaler not only marks a significant achievement for Vital Reaction but also reinforces Onfolio Holdings’ commitment to fostering innovation and growth across its portfolio of companies.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.